The immunotoxicity, but not anti-tumor efficacy, of anti-CD40 and anti-CD137 immunotherapies is dependent on the gut microbiota.
Blake SJ, James J, Ryan FJ, Caparros-Martin J, Eden GL, Tee YC, Salamon JR, Benson SC, Tumes DJ, Sribnaia A, Stevens NE, Finnie JW, Kobayashi H, White DL, Wesselingh SL, O'Gara F, Lynn MA, Lynn DJ.
Blake SJ, et al. Among authors: o gara f.
Cell Rep Med. 2021 Dec 8;2(12):100464. doi: 10.1016/j.xcrm.2021.100464. eCollection 2021 Dec 21.
Cell Rep Med. 2021.
PMID: 35028606
Free PMC article.